🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT07162129
Active, not recruiting Not applicable

Online Transdiagnostic Group CBT for Postpartum Depression and Anxiety

NCT07162129 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2025-09-09
Last updated
2026-01-26

Condition(s) studied

Postpartum Depression (PPD)Postpartum Anxiety

Investigational drug(s) / intervention(s)

Cognitive Behavioral Therapy for Postpartum Depression (PPD) and Anxiety

Cognitive Behavioral Therapy for Postpartum Depression (PPD) and Anxiety: Cognitive Behavioral Therapy (CBT) is a type of psychotherapy (talk therapy). Each session will be two hours in duration. The 1st hour involves teaching and practice of CBT skills followed by one hour of unstructured discussion about topics relevant to PPD and PPA (sleep, supports, transitions). Each group will be delivered online via Zoom and guided by our intervention manual.

Study summary

The purpose of this pilot study is to test the feasibility of an online 10-Week group cognitive behavioural therapy (CBT; a type of talking therapy) intervention for postpartum depression and anxiety that is led by psychotherapists, social workers, a psychologist and/or a psychiatrist. Mothers and birthing parents who are 18 years or older, have an infant under 12 months, living in Ontario and who have postpartum depression and/or anxiety symptoms will be assigned with a 50/50 chance (like flipping a coin) to receive online transdiagnostic group CBT in addition to usual postnatal care, or to receive usual postnatal care only.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * ≥18 years old * have an infant \<12 months at recruitment * fluent in written/spoken English * have an EPDS score ≥10 and/or a GAD-7 score≥10 * live in Ontario, Canada Exclusion Criteria: * does not meet diagnostic criteria for bipolar, psychotic, borderline personality and current substance use disorders

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
McMaster University Hamilton Ontario

More McMaster University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07162129 on ClinicalTrials.gov ↗ ← All trials in Canada